BridgeBio Pharma Inc. (BBIO) Earnings
|
Expand Research on BBIO
| Next EPS Date | 7/30/26 | EPS Growth Rate | +37.9% |
|---|---|---|---|
| Average EPS % Beat Rate | -24.3% | Revenue Growth Rate | +98.4% |
| Average % Move 1-Wk after EPS | -3.5% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
7/30/26  |
Q226 | N/A | -$0.59 | N/A | N/A | $219.3M | N/A | N/A | N/A | ||
| 5/7/26 |
Q126 | -$0.84 | -$0.68 | -$0.16 | $194.5M | $178.16M | N/A |  | | Details | |
| 5/5/26 |
Q126 | N/A | -$0.68 | N/A | N/A | $178.16M | N/A | N/A | N/A | ||
| 5/4/26 |
Q126 | N/A | -$0.68 | N/A | N/A | $178.16M | N/A | N/A | N/A | ||
| 5/1/26 |
Q126 | N/A | -$0.68 | N/A | N/A | $178.16M | N/A | N/A | N/A | ||
| 4/30/26 |
Q126 | N/A | -$0.68 | N/A | N/A | $178.16M | N/A | N/A | N/A | ||
| 2/24/26 | Q425 | -$1.00 | -$0.72 | -$0.28 | $154.2M | $146.16M | N/A | | | Details | |
| 10/29/25 | Q325 | -$0.95 | -$0.88 | -$0.07 | $120.7M | $107.62M | N/A | | | Details |
